Better Diabetes Control, Quality - Educate to Achieve Compliance.

AstraZeneca227 enrolled

Overview

Prospective study to evaluate the impact of an educational programme about diabetes, comparing to normal clinical practice, on treatment compliance and disease control of people with type 2 diabetes followed in the primary care units in Portugal

Prospective study to evaluate the impact of an educational programme about diabetes focusing on treatment compliance, exercise and nutrition, comparing to normal clinical practice, on treatment compliance and disease control of people with type 2 diabetes followed in the primary care units in Portugal.

Study Type

OBSERVATIONAL

Enrollment

227

Conditions

Diabetes Type 2

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Individuals with type 2 diabetes * HbA1c \<= 8,5% * Treated with oral antidiabetics for at least 6 months Exclusion Criteria: \- Treatment with insulin

Locations (5)

Research Site

Almada, Portugal

Research Site

Espinho, Portugal

Research Site

Loures, Portugal

Research Site

Oeiras, Portugal

Research Site

Santo Antonio Dos Cavaleiros, Portugal

Outcomes

Primary Outcomes

Number of people with type 2 diabetes treated with oral antidiabetics assessed as compliant with treatment after 1 year educational programme on diabetes, compared with normal clinical practice.

Time frame: 1 year

Secondary Outcomes

Number of people with type 2 diabetes treated with oral antidiabetics assessed as compliant with diet and physical exercise after 1 year educational programme on diabetes, compared with normal clinical practice.

Time frame: 1 year

Number of people with type 2 diabetes treated with oral antidiabetics assessed as compliant with treatment with oral antidiabetics;after 1 year educational programme on diabetes, compared with normal clinical practice.

Time frame: 1 year

Measure impact on quality of life, perceived by the patient, following 1 year educational programme on diabetes, compared with normal clinical practice.

Time frame: 1 year

Measure the impact of compliance with treatment on glucose control following 1 year educational programme on diabetes, compared with normal clinical practice.

Time frame: 1 year

Measure level of satisfaction of the patient with treatment and medical care following 1 year educational programme on diabetes, compared with normal clinical practice.

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.